| Dr Lacey Giambelluca, MD | |
|
726 N Acadia Rd Ste 1000, Thibodaux, LA 70301-5051 | |
| (985) 625-2200 | |
| (985) 625-2206 |
| Full Name | Dr Lacey Giambelluca |
|---|---|
| Gender | Female |
| Speciality | Orthopaedic Surgery - Foot And Ankle Surgery |
| Location | 726 N Acadia Rd Ste 1000, Thibodaux, Louisiana |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1942738372 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207XX0004X | Orthopaedic Surgery - Foot And Ankle Surgery | 336108 (Louisiana) | Primary |
| Entity Name | Lacey Giambelluca Md Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1669247037 PECOS PAC ID: 1052769676 Enrollment ID: O20231121000409 |
News Archive
The dynamics of angiotensin-converting enzyme 2 (ACE2) expression in the kidney could have implications for the infectivity and pathogenicity of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), say researchers.
Retina Implant AG, the leading developer of subretinal implants for retinitis pigmentosa patients, today announced that its scientific advisory board is in full support of beginning the multi-center phase of the Company's second human clinical trial. The trial, which began in Tuebingen, Germany in 2010, will be expanded across Europe in five new sites, including two additional locations in Germany, Oxford, London and Budapest.
Jennerex, Inc., a private clinical-stage biotherapeutics company focused on the development and commercialization of first-in-class targeted oncolytic products for cancer, and Transgene, a bio-pharmaceutical company specialized in the development of immunotherapeutic products, today announced that enrollment and treatment of patients in a Phase 1b clinical trial has been initiated to evaluate JX-594 in patients with advanced metastatic, refractory colorectal cancer (CRC).
The US Food and Drug Administration (FDA) has cleared the neuropsychological test - QbTest - developed by the Swedish company Qbtech to aid in the evaluation of treatment interventions in patients with ADHD.
"As the recession has cost more people their jobs and their health insurance, local hospitals have seen more patients show up with no way to pay," reports KUOW, a Washington State public radio station.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Lacey Giambelluca, MD Po Box 28, Thibodaux, LA 70302-0028 Ph: () - | Dr Lacey Giambelluca, MD 726 N Acadia Rd Ste 1000, Thibodaux, LA 70301-5051 Ph: (985) 625-2200 |
News Archive
The dynamics of angiotensin-converting enzyme 2 (ACE2) expression in the kidney could have implications for the infectivity and pathogenicity of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), say researchers.
Retina Implant AG, the leading developer of subretinal implants for retinitis pigmentosa patients, today announced that its scientific advisory board is in full support of beginning the multi-center phase of the Company's second human clinical trial. The trial, which began in Tuebingen, Germany in 2010, will be expanded across Europe in five new sites, including two additional locations in Germany, Oxford, London and Budapest.
Jennerex, Inc., a private clinical-stage biotherapeutics company focused on the development and commercialization of first-in-class targeted oncolytic products for cancer, and Transgene, a bio-pharmaceutical company specialized in the development of immunotherapeutic products, today announced that enrollment and treatment of patients in a Phase 1b clinical trial has been initiated to evaluate JX-594 in patients with advanced metastatic, refractory colorectal cancer (CRC).
The US Food and Drug Administration (FDA) has cleared the neuropsychological test - QbTest - developed by the Swedish company Qbtech to aid in the evaluation of treatment interventions in patients with ADHD.
"As the recession has cost more people their jobs and their health insurance, local hospitals have seen more patients show up with no way to pay," reports KUOW, a Washington State public radio station.
› Verified 6 days ago
John Christian Hildenbrand Iv, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 726 N Acadia Rd, Suite 1000, Thibodaux, LA 70301 Phone: 985-625-2200 Fax: 985-625-2206 | |
Dr. Eric Mckenzie Greber, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 726 N Acadia Rd Ste 1000, Thibodaux, LA 70301 Phone: 985-625-2200 Fax: 985-625-2206 | |
Dr. Richard A Morvant Jr., M.D. Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 726 N Acadia Rd, Suite 1000, Thibodaux, LA 70301 Phone: 985-625-2200 Fax: 985-625-2206 | |
Dr. David Wadie Elias, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 726 N Acadia Rd, Suite 1000, Thibodaux, LA 70301 Phone: 985-625-2200 Fax: 985-625-2206 | |
Neil James Maki, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 525 Saint Mary St, Thibodaux, LA 70301 Phone: 985-446-6824 | |
Dr. Patrick Roan Ellender, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 726 N Acadia Rd, Suite 1000, Thibodaux, LA 70301 Phone: 985-625-2200 Fax: 985-625-2206 | |
Dr. Jason A. Higgins, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 726 N Acadia Rd, Suite 1000, Thibodaux, LA 70301 Phone: 985-625-2200 Fax: 985-625-2206 |